Tsuruha Holdings Inc. (TYO:3391)
Japan · Delayed Price · Currency is JPY 2,372.50
-37.50 (-1.56%)
Sep 19, 2025, 2:45 PM JST
Tsuruha Holdings Revenue
In the fiscal year ending February 28, 2025, Tsuruha Holdings had annual revenue of 1.01T JPY, down -1.24%. Tsuruha Holdings had revenue of 272.53B in the quarter ending May 31, 2025, with 7.57% growth.
Revenue (ttm)
1,098.95B
Revenue Growth
+6.96%
P/S Ratio
0.58
Revenue / Employee
89.81M
Employees
11,298
Market Cap
586.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 1,014.72B | -12.74B | -1.24% |
| May 15, 2024 | 1,027.46B | 57.38B | 5.92% |
| May 15, 2023 | 970.08B | 54.38B | 5.94% |
| May 15, 2022 | 915.70B | -3.60B | -0.39% |
| May 15, 2021 | 919.30B | 78.27B | 9.31% |
| May 15, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 15, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 15, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 15, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 15, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| HOYA Corporation | 876.09B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |